| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|

Fig. 4. Normalization of aMT6s excretion in patients with DSPS treated with exogenous melatonin. Note the low levels of aMT6s during the initial half of daytime (cf, Figure 3).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |